Examiner.com: New peer reviewed study strongly links autism to vaccine induced type 1 diabetes


Originally published at Examiner.com in HEALTH NEWS

JULY 14, 2013


On Friday, July 12, Classen Immunotherapies, Inc. issued a press release about a new peer reviewed study that was published in the current issue of Open Access, Scientific Reports (Volume 2, Issue 3, 2013) linking the autism epidemic to the epidemic of vaccine induced type 1 diabetes.

The press release stated:

Growing evidence shows that a large percentage of cases of autism have an inflammatory or autoimmune component. The new data shows autism is strongly linked to type 1 diabetes another epidemic inflammatory disease where the epidemic has been proven to be caused by vaccines.

Immunologist J. Bart Classen, MD authored the new paper. In the press release, Dr. Classen, says, “We have been publishing for many years that vaccine induced inflammation is causing an epidemic of type 1 diabetes and other diseases. Our new data, as well as the extensive data from others regarding the role of inflammation in the development autism, leaves little doubt vaccines play a significant role in the autism epidemic.”

The large number of vaccines given to patients is leading to an epidemic of chronic inflammation resulting in epidemics of autoimmune diseases and allergies according to Dr. Classen’s research.

An Italian court ruled in favor of the Bocca family whose nine-year-old son became autistic after receiving the MMR (Measles/Mumps & Rubella) vaccine. See: http://www.examiner.com/article/us-media-blackout-court-rules-that-mmr-vaccine-caused-autism

Source: http://finance.yahoo.com/news/autism-epidemic-linked-epidemic-vaccine-100000000.html


Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Share on RedditPin on PinterestFlattr the authorDigg thisBuffer this pageShare on TumblrShare on StumbleUpon

22 Thoughts on “Examiner.com: New peer reviewed study strongly links autism to vaccine induced type 1 diabetes

  1. Carlyle on July 15, 2013 at 1:59 pm said:

    “Open Access Scientific Reports” is an OMICS “journal,” deceptively named to sound like the one published by Nature. They also have a bad habit of putting random people on “editorial boards” without their consent. Any claims of being “peer reviewed” are wishful thinking.

    Hilariously, this two-page entry claims to have been submitted nearly 19 months ago.

    • “…deceptively named to sound like the one published by Nature.” So it’s a conspiracy to look like a Nature journal, is that right?

      • Carlyle on July 16, 2013 at 6:06 pm said:

        “So it’s a conspiracy to look like a Nature journal, is that right?”

        A conspiracy? No, but it’s what OMICS does, and IIRC, their bogus-conference arm pulls the same stunt. If you’re not familiar with them, you ought to be. Jeffrey Beall’s scholarlyoa.com is a good place to start. As I stated, they also put people from unrelated discliplines on fake editorial boards.

      • Carlyle on July 16, 2013 at 6:47 pm said:

        One ought not to forget this OMICS classic, either, in which they put a nonexistent person on the Editorial Board of “Molecular Biology.”

  2. Carlyle on July 15, 2013 at 2:13 pm said:

    One might also note that causation wasn’t at issue in the Italian case, falsifying that sentence in the press release. And that there are no “new data” in Classen’s entry, taking out at least two more.

    • “causation wasn’t at issue in the Italian case” Well, it was since the child was compensated for an MMR vaccine injury.

      • Carlyle on July 16, 2013 at 6:11 pm said:

        “‘causation wasn’t at issue in the Italian case’ Well, it was since the child was compensated for an MMR vaccine injury.”

        This is not sound reasoning. My recollection is that the Ministry of Health elected not even to bother with the causation issue because they thought another government agency should be responsible for the benefits, based on the timing of the claim. This strategy failed. You’re perfectly free to research it yourself.

      • Carlyle on July 16, 2013 at 6:15 pm said:

        And I would note that you did not address the (lack of) “new data” issue. This is a two-page, open-access paper, which I assume your professional training would allow you to assess in a more detailed manner than simply pointing at a press release.


    Rather than linking “autism” and “vaccine-induced [childhood] type-1 diabetes”, the article establishes a correlation between “autism” and “childhood type-1 diabetes”. Because the putative cause of the childhood type-1 diabetes is vaccine-inoculation related, these findings indicate that both “autism” and “childhood type-1 autism” are probably causally linked to the current recommended national childhood vaccination programs and the overall adherence thereto by the parents of more than 95% of the children.

    When considered with all of the other chronic childhood diseases that may be or have been shown to have some linkage to one or more vaccination programs, the overall reality is that the current national childhood vaccination programs are a correlationally confirmed, causal risk factor for many chronic childhood medical conditions (diseases, syndromes, disorders, behaviors).

  4. sam hall on July 16, 2013 at 9:58 am said:

    Glad to see this post. This paper appears to be a scorching vindication of what many others have been saying for a long time. To read it all in a couple of paragraphs has to be a real worry to some folk.

    I am surprised more sites have not written more about the Classen paper ?

    • sam,

      It is interesting, isn’t it? Two disorders the medical community officially sees as being completely unrelated to each other being linked together in this very politically inconvenient way.

      The last time I cited anything by Dr. Classen was in an article I had written for Age of Autism last year about a conversation I had with IACC Chair Tom Insel at the July 2012 meeting. Insel tried to play down the significance of his brother’s work on the Hib vaccine as a potential COI by claiming he now heads a group dedicated to fighting juvenile diabetes, which the Hib vaccine is also suspected of causing.

      Yet, Age of Autism has chosen to ignore this paper.

  5. Rebecca Fisher on July 16, 2013 at 11:24 am said:


    Given that you’re always keen on exposing real or imagined financial conflicts of interest, it’s probably worth mentioning this statement which used to appear on the Classen website:

    “Classen Immunotherapies believe that its technology is essential technology based on the large unnecessary risk of developing IDDM using current technology. The cost savings as well as laws governing safety of pharmaceuticals will force all vaccine manufacturers to utilize Classen Immunotherpies’ proprietary technology.”


    Kind regards,


    • You can look up each of the conflicts of interest I’ve uncovered and see for yourself if they are “imagined” or not. I’m sure Classen Immunotherapies would appreciate your plug.


  6. Rebecca Fisher on July 17, 2013 at 7:11 am said:

    So you don’t see this as a conflict of interest? Interesting.

  7. Rebecca Fisher on July 17, 2013 at 6:47 pm said:

    Ah – so you do see it as a conflict of interest then?

    And before you answer “I never said that” to this one, let’s ask a couple of straight, mostly closed question:

    Do you see the phrase I quoted above from the Classen website (http://web.archive.org/web/19990422105459/http://vaccines.net/newpage4.htm) as a conflict of interest?

    If so, why do you consider the Classen paper valid, when your previous work at Age of Autism has mainly involved dismissing other work because of conflicts of interest?

    Kind regards,


    • I don’t dismiss other work based on conflicts of interest, but I believe conflicts of interest are important in putting the objectivity of peoples’ work into perspective.

      • Rebecca Fisher on July 18, 2013 at 6:59 am said:


        Stop trying to dodge the question.

        Do you see the phrase I quoted above from the Classen website as a conflict of interest which should have been revealed, and should be taken into account when assessing the objectivity of the Classen paper?

        Kind regards,


        • I’m not, and yes I do, but I think readers can figure out for themselves that “Classen Immunotherapies Inc” is a private firm. This article links directly to the Classen press release, which refers readers to the Classen website where you found that description.


Leave a Reply

Your email address will not be published. Required fields are marked *

Post Navigation